banner
MEK inhibitor PD318088, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ854

MEK inhibitor PD318088, Purity ≥98%

Synonym: PD318088; 391210-00-7; PD-318088; 5-Bromo-N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide; PD0318088; 5-Bromo-N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide; MEK inhibitor

  • CAS Number: 391210-00-7
  • Compound CID: 10231331
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
PD318088, soluble in DMSO and ethanol and insoluble in water, prevents the phosphorylation and activation of ERK leading to reduced cell proliferation and induced apoptosis in cancerous cells. It targets MEK1/2.
Molecular Weight
561.1
Molecular Formula
C16H13BrF3IN2O4
Targets
MEK1/2
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 105 mg/mL (187.13 mM); Water: Insoluble; Ethanol: 13 mg/mL (23.17 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
PD318088 can be used to investigate the inhibition of MEK1/2 in signal transduction and its effects on tumor growth.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0